Article thumbnail

Evaluation of the combined use of adiponectin and C-reactive protein levels as biomarkers for predicting the deterioration in glycaemia after a median of 5.4 years

By K. L. Ong, A. W. K. Tso, A. Xu, L. S. C. Law, M. Li, N. M. S. Wat, K. A. Rye, T. H. Lam, B. M. Y. Cheung and K. S. L. Lam
Topics: Article
Publisher: Springer-Verlag
OAI identifier: oai:pubmedcentral.nih.gov:3168746
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (1984). A et al (2003) C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study,
  2. (2006). Abdominal obesity and metabolic syndrome.
  3. (2008). Adipokines and incident type 2 diabetes in an Aboriginal Canadian population: the Sandy Lake Health and Diabetes Project. Diabetes Care 31:1410–
  4. (2002). Adiponectin and development of type 2 diabetes in the Pima Indian population.
  5. (2004). Adiponectin and protection against type 2 diabetes mellitus.
  6. (2008). Adiponectin decreases C-reactive protein synthesis and secretion from endothelial cells: evidence for an adipose tissue-vascular loop. Arterioscler Thromb V asc
  7. (2008). Adipose tissue and the metabolic syndrome: focusing on adiponectin and several novel adipokines.
  8. Arita Yet al (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb V asc
  9. (2009). Association of Creactive protein with type 2 diabetes: prospective analysis and meta-analysis.
  10. (2007). C-reactive protein inhibits adiponectin gene expression and secretion in 3 T3-L1 adipocytes.
  11. (2003). C-reactive protein predicts the deterioration of glycemia in Chinese subjects with impaired glucose tolerance. Diabetes Care 26:2323–2328
  12. (2001). C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.
  13. (2008). Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.
  14. Colvin A et al (2008) Ethnic differences in C-reactive protein concentrations.
  15. Das SR et al (2009) Sex differences in the relationship between C-reactive protein and body fat.
  16. (2007). Development of diabetes in Chinese with the metabolic syndrome: a 6-year prospective study. Diabetes Care 30:1430–1436
  17. (2001). Elevated Creactive protein: another component of the atherothrombotic profile of abdominal obesity.
  18. (2010). High glucose upregulates C-reactive protein synthesis in macrophages.
  19. (2002). Insulin Resistance Atherosclerosis Study
  20. (2003). Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study.
  21. (1996). Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.
  22. (1999). Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.
  23. (2006). Polymorphisms of the gene encoding adiponectin and glycaemic outcome of Chinese subjects with impaired glucose tolerance: a 5-year follow-up study.
  24. (2008). Reduced highmolecular-weight adiponectin and elevated high-sensitivity Creactive protein are synergistic risk factors for metabolic syndrome in a large-scale middle-aged to elderly population: the Shimanami Health Promoting Program Study.
  25. (2011). Serum C-reactive protein level and prediabetes in two Asian populations.
  26. (2007). Sex differences in the prediction of type 2 diabetes by inflammatory markers: results from the MONICA/KORA Augsburg case–cohort study,
  27. Stehouwer CD et al (2003) Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian. Diabetes Care
  28. Tamakoshi K et al (2006) Comparison of circulating adiponectin and proinflammatory markers regarding their association with metabolic syndrome
  29. (2007). The metabolic syndrome and vascular disease in Asia. Cardiovasc Hematol Disord Drug Targets 7:79–85
  30. (2001). The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study.
  31. Tso AW et al (2010) Association of genetic variants in the adiponectin gene with adiponectin level and hypertension in Hong Kong Chinese.
  32. (2010). Usefulness of C-reactive protein to high-molecular-weight adiponectin ratio to predict insulin resistance and metabolic syndrome in Japanese men.
  33. (2007). Visceral adipose tissue accumulation differs according to ethnic background: results of the Multicultural Community Health Assessment Trial (M-CHA T).
  34. (2010). Xu A